Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera

Supasa P., Zhou D., Dejnirattisai W., Liu C., Mentzer AJ., Ginn HM., Zhao Y., Duyvesteyn HME., Nutalai R., Tuekprakhon A., Wang B., Paesen GC., Slon-Campos J., López-Camacho C., Hallis B., Coombes N., Bewley KR., Charlton S., Walter TS., Barnes E., Dunachie SJ., Skelly D., Lumley SF., Baker N., Shaik I., Humphries HE., Godwin K., Gent N., Sienkiewicz A., Dold C., Levin R., Dong T., Pollard AJ., Knight JC., Klenerman P., Crook D., Lambe T., Clutterbuck E., Bibi S., Flaxman A., Bittaye M., Belij-Rammerstorfer S., Gilbert S., Hall DR., Williams MA., Paterson NG., James W., Carroll MW., Fry EE., Mongkolsapaya J., Ren J., Stuart DI., Screaton GR.